CSE/FNT.U (CSE/FNT.U)

Canadian Securities Exchange: CSE/FNT.U · USD

$0.02

+0.00 (0.0%)· Recorded snapshot

Market cap	13.4M
Revenue (ttm)	107.9M
Net income (ttm)	-113.8M
EPS (ttm)	-$0.18
Shares out	638M
Volume	14,000
Beta	0.77

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 107.9M
Net income (ttm): -113.8M
EPS (ttm): -$0.18
Market cap: 13.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-22.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/FNT.U indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Employees	826
Enterprise value	$212M
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2015
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA34380L1022
Last earnings date	2025-11-28
Last refreshed	2026-10-29
Market cap	$13.4M
Next earnings date	2026-11-27
Price	$0.02
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	cse/FNT.U
Website	https://investors.getfluent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-871.82%
EV/Sales	1.99x
FCF / EV yield	-5.18%
FCF yield	-81.78%
Industry forward P/E	34.4x
P/S ratio	0.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-31.13%
EBITDA margin	-20.93%
Gross margin	24.25%
Operating margin	-31.13%
Pretax margin	-104.66%
Profit margin	-105.48%
ROA	-8.46%
ROA (5Y)	0.07%
ROCE	-24.17%
ROIC	-22.77%
SBC / revenue	0.21%
Tax / revenue	17.28%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-43.9%
Gross profit growth (Q)	44.53%
Gross profit growth 3Y	-19.13%
Gross profit growth 5Y	-5.39%
OCF growth (Q)	-76.07%
Revenue growth	-5.75%
Revenue growth (Q)	-24.97%
Revenue growth (QoQ)	-4.32%
Revenue growth 3Y	-6.2%
Revenue growth 5Y	4.64%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-6M
Depreciation and amortization	$10.8M
EBIT	$-33.6M
EBITDA	$-22.6M
EPS	$-0.18
FCF per share	$-0.02
Financing cash flow	$-30.6M
Free cash flow	$-11M
Free cash flow minus SBC	$-11.2M
Gross profit	$26.2M
Income taxes	$18.6M
Investing cash flow	$9.5M
Net borrowing	$-30.4M
Net cash flow	$-26M
Net income	$-113.8M
Operating cash flow minus SBC	$-5.2M
Operating income	$-33.6M
Revenue	$107.9M
Stock-based compensation	$228,636

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.77
Book value per share	$-0.24
Goodwill	$2.1M
Interest coverage	-1.08
Long-term assets	$153.8M
Long-term liabilities	$291.5M
Net cash (debt)	$-201M
Net cash / market cap	-1,496.15%
Piotroski F-Score	3
Property, plant and equipment	$100.9M
Shareholders' equity	$-151.7M
Tangible book value	$-200.4M
Tangible book value per share	$-0.31
Total assets	$189.8M
Total cash	$3.6M
Total debt	$204.5M
Total liabilities	$341.5M
WACC	11.81%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	$36M
Current liabilities	$50M
Current ratio	0.72
Inventory turnover	3.12
Net working capital	$3.6M
Quick ratio	0.1
Working capital	$-14.3M
Working capital turnover	19.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-60.45%
Shareholder yield	-60.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.03
1D price change	0%
1M price change	-25%
1M total return	-25%
1W price change	-25%
1W total return	-25%
1Y price change	-72.73%
1Y return CAGR	-72.75%
1Y total return	-72.73%
20-day SMA	$0.02
200-day SMA	$0.03
3M price change	-25%
3M total return	-25%
3Y price change	-84.21%
3Y return CAGR	-45.94%
3Y total return	-84.21%
50-day SMA	$0.02
50-day SMA vs 200-day SMA	50under200
52-week high	$0.08
52-week high date	2025-12-17
52-week low	$0.02
52-week low date	2026-10-28
5Y price change	-97.76%
5Y return CAGR	-53.23%
5Y total return	-97.76%
6M price change	-57.14%
6M total return	-57.14%
All-time high	$2.20
All-time high date	2019-03-22
All-time low	$0.02
All-time low date	2026-10-09
Average true range (ATR)	$0.00
Average volume	104.4K
Beta (1Y)	0.57
Beta (2Y)	0.25
Beta (5Y)	0.77
Change from 52-week high	-81.25%
Change from 52-week low	0%
Change from all-time high	-99.32%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	$210
High price	$0.02
Low price	$0.02
Monthly RSI	31.98
Open price	$0.02
Previous close	$0.02
Price vs 150-day SMA	-45.45%
Price vs 20-day SMA	-20.21%
Price vs 200-day SMA	-54.68%
Price vs 50-day SMA	-25%
Relative volume	0.13
RSI	39.84
Sharpe ratio	-0.01
Sharpe ratio (3Y)	0.3
Sharpe ratio (5Y)	-0.07
Sortino ratio	0.01
Sortino ratio (3Y)	0.54
Sortino ratio (5Y)	-0.05
Volume	14K
Weekly RSI	31.56
YTD price change	-70%
YTD total return	-70%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	384.7M
Shares change (QoQ)	0.2%
Shares change (YoY)	60.45%
Shares held by insiders	11.86%
Shares held by institutions	1.78%
Shares outstanding	638M

Deeper analysis on CSE/FNT.U

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/FNT.U report

Is a complete CSE/FNT.U research report available?

No complete published report is available for cse/FNT.U (CSE/FNT.U) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/FNT.U (CSE/FNT.U)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/FNT.U

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/FNT.U indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/FNT.U

Frequently asked questions